Yuyu Pharma, Inc. (KRX:000220)

Yuyu Pharma Statistics

Total Valuation

Yuyu Pharma has a market cap or net worth of KRW 65.18 billion. The enterprise value is 78.29 billion.

Market Cap	65.18B
Enterprise Value	78.29B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

Yuyu Pharma has 15.76 million shares outstanding. The number of shares has decreased by -4.43% in one year.

Current Share Class	15.76M
Shares Outstanding	15.76M
Shares Change (YoY)	-4.43%
Shares Change (QoQ)	+30.06%
Owned by Insiders (%)	35.92%
Owned by Institutions (%)	0.04%
Float	10.10M

Valuation Ratios

The trailing PE ratio is 16.79.

PE Ratio	16.79
Forward PE	n/a
PS Ratio	0.48
PB Ratio	0.48
P/TBV Ratio	0.55
P/FCF Ratio	5.80
P/OCF Ratio	3.75
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.95, with an EV/FCF ratio of 6.97.

EV / Earnings	19.82
EV / Sales	0.58
EV / EBITDA	4.95
EV / EBIT	7.69
EV / FCF	6.97

Financial Position

The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.21.

Current Ratio	1.66
Quick Ratio	0.82
Debt / Equity	0.21
Debt / EBITDA	1.83
Debt / FCF	2.55
Interest Coverage	3.47

Financial Efficiency

Return on equity (ROE) is 4.78% and return on invested capital (ROIC) is 3.83%.

Return on Equity (ROE)	4.78%
Return on Assets (ROA)	3.13%
Return on Invested Capital (ROIC)	3.83%
Return on Capital Employed (ROCE)	6.99%
Revenue Per Employee	532.75M
Profits Per Employee	15.55M
Employee Count	254
Asset Turnover	0.68
Inventory Turnover	1.91

Taxes

Income Tax	-114.58M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.11% in the last 52 weeks. The beta is 0.27, so Yuyu Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.27
52-Week Price Change	-7.11%
50-Day Moving Average	4,288.10
200-Day Moving Average	4,500.45
Relative Strength Index (RSI)	35.29
Average Volume (20 Days)	52,147

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Yuyu Pharma had revenue of KRW 135.32 billion and earned 3.95 billion in profits. Earnings per share was 246.23.

Revenue	135.32B
Gross Profit	51.45B
Operating Income	10.01B
Pretax Income	6.16B
Net Income	3.95B
EBITDA	15.64B
EBIT	10.01B
Earnings Per Share (EPS)	246.23

Balance Sheet

The company has 28.78 billion in cash and 28.67 billion in debt, giving a net cash position of 109.90 million or 6.97 per share.

Cash & Cash Equivalents	28.78B
Total Debt	28.67B
Net Cash	109.90M
Net Cash Per Share	6.97
Equity (Book Value)	134.75B
Book Value Per Share	7,709.34
Working Capital	38.16B

Cash Flow

In the last 12 months, operating cash flow was 17.39 billion and capital expenditures -6.15 billion, giving a free cash flow of 11.24 billion.

Operating Cash Flow	17.39B
Capital Expenditures	-6.15B
Free Cash Flow	11.24B
FCF Per Share	713.13

Margins

Gross margin is 38.02%, with operating and profit margins of 7.40% and 3.76%.

Gross Margin	38.02%
Operating Margin	7.40%
Pretax Margin	4.55%
Profit Margin	3.76%
EBITDA Margin	11.56%
EBIT Margin	7.40%
FCF Margin	8.31%

Dividends & Yields

This stock pays an annual dividend of 100.00, which amounts to a dividend yield of 2.43%.

Dividend Per Share	100.00
Dividend Yield	2.43%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	37.86%
Buyback Yield	4.43%
Shareholder Yield	6.86%
Earnings Yield	6.06%
FCF Yield	17.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 30, 2021. It was a forward split with a ratio of 2.

Last Split Date	Mar 30, 2021
Split Type	Forward
Split Ratio	2

Scores

Yuyu Pharma has an Altman Z-Score of 1.92 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.92
Piotroski F-Score	7